These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16257123)

  • 21. A heterozygous effect for PINK1 mutations in Parkinson's disease?
    Abou-Sleiman PM; Muqit MM; McDonald NQ; Yang YX; Gandhi S; Healy DG; Harvey K; Harvey RJ; Deas E; Bhatia K; Quinn N; Lees A; Latchman DS; Wood NW
    Ann Neurol; 2006 Oct; 60(4):414-9. PubMed ID: 16969854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel P-TEN-induced putative kinase 1 (PINK1) variant in Indian Parkinson's disease patient.
    Halder T; Raj J; Sharma V; Das P
    Neurosci Lett; 2015 Sep; 605():29-33. PubMed ID: 26282903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients.
    Godeiro-Junior C; de Carvalho-Aguiar PM; Felício AC; Barsottini OG; Silva SM; Borges V; Andrade LA; Ferraz HB
    Mov Disord; 2009 Aug; 24(11):1693-6. PubMed ID: 19562775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the PINK1 gene in Southern Italian patients with early- and late-onset parkinsonism.
    Scornaienchi V; Civitelli D; De Marco EV; Annesi G; Tarantino P; Rocca FE; Greco V; Provenzano G; Annesi F; Nicoletti G; Colica C; Uncini A; Salsone M; Novellino F; Morelli M; Arabia G; Gambardella A; Quattrone A
    Parkinsonism Relat Disord; 2012 Jun; 18(5):651-3. PubMed ID: 21925922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Parkinsonism with digenic parkin and PINK1 mutations.
    Funayama M; Li Y; Tsoi TH; Lam CW; Ohi T; Yazawa S; Uyama E; Djaldetti R; Melamed E; Yoshino H; Imamichi Y; Takashima H; Nishioka K; Sato K; Tomiyama H; Kubo S; Mizuno Y; Hattori N
    Mov Disord; 2008 Jul; 23(10):1461-5. PubMed ID: 18546294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.
    Rogaeva E; Johnson J; Lang AE; Gulick C; Gwinn-Hardy K; Kawarai T; Sato C; Morgan A; Werner J; Nussbaum R; Petit A; Okun MS; McInerney A; Mandel R; Groen JL; Fernandez HH; Postuma R; Foote KD; Salehi-Rad S; Liang Y; Reimsnider S; Tandon A; Hardy J; St George-Hyslop P; Singleton AB
    Arch Neurol; 2004 Dec; 61(12):1898-904. PubMed ID: 15596610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.
    Schlitter AM; Kurz M; Larsen JP; Woitalla D; Mueller T; Epplen JT; Dekomien G
    J Negat Results Biomed; 2005 Dec; 4():10. PubMed ID: 16354302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases.
    Tan AH; Lohmann K; Tay YW; Lim JL; Ahmad-Annuar A; Ramli N; Chin YT; Mawardi AS; Azmi K; Aziz ZA; Puvanarajah SD; Bauer P; Klein C; Rolfs A; Lim SY
    Parkinsonism Relat Disord; 2020 Oct; 79():34-39. PubMed ID: 32861104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive assessment of PINK1 variants in Parkinson's disease.
    Krohn L; Grenn FP; Makarious MB; Kim JJ; Bandres-Ciga S; Roosen DA; Gan-Or Z; Nalls MA; Singleton AB; Blauwendraat C;
    Neurobiol Aging; 2020 Jul; 91():168.e1-168.e5. PubMed ID: 32249012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
    Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological findings in PINK1-associated Parkinson's disease.
    Nybø CJ; Gustavsson EK; Farrer MJ; Aasly JO
    Parkinsonism Relat Disord; 2020 Sep; 78():105-108. PubMed ID: 32814227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
    Ibáñez P; Lesage S; Lohmann E; Thobois S; De Michele G; Borg M; Agid Y; Dürr A; Brice A;
    Brain; 2006 Mar; 129(Pt 3):686-94. PubMed ID: 16401616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese.
    Wang F; Feng X; Ma J; Zou H; Chan P
    Neurosci Lett; 2006 Dec; 410(2):121-5. PubMed ID: 17084972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients.
    Deng H; Le WD; Zhang X; Pan TH; Jankovic J
    Acta Neurol Scand; 2005 Jun; 111(6):351-2. PubMed ID: 15876334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease.
    Keyser RJ; Lesage S; Brice A; Carr J; Bardien S
    Biochem Biophys Res Commun; 2010 Jul; 398(1):125-9. PubMed ID: 20558144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PINK1 protein in normal human brain and Parkinson's disease.
    Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
    Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.